The report "Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Test Type (Mycoplasma, Sterility, Endotoxin, Bioburden, Virus Safety), Application (Vaccines, mAbs, Cell & Gene Therapy, Blood Products) - Global Forecast to 2029", is projected to reach USD 7.2 billion by 2029 from an estimated USD 4.2 billion in 2024, at a CAGR of 11.1%...
Biologics safety testing market research and analysis by product, test, application — forecast till 2027. The global biologics safety testing market is expected to grow at a robust 13.6% CAGR over the forecast period (2022 to 2027), according to the latest research report from Market Research Future (MRFR). As biologics are increasingly used in medication development and stem cell...
Biologics Safety Testing Market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 13.3% during the forecast period according to a new report by MarketsandMarkets™. The growth of the global biologics safety testing market is driven by factors such as companies investing heavily in the development of biologics...
According to the new market research report "Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Application (Vaccine, Monoclonal Antibodies, Blood products, Cell & Gene Therapy Products), Test Type (Endotoxin, Myoplasm, Sterility Test) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 6.2...
Bharat Book Bureau Provides the Trending Market Research Report on“Biologics Safety Testing Market by Product & Service (Instruments, Consumables, Services), Application (mAbs, Vaccine, Cell & Gene Therapy), Test Type (Sterility Test, Endotoxin, Mycoplasma, Bioburden), End User (Biopharma, CDMO) - Global Forecast to 2027”under Life sciences Market Research Report Category....
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian